Fluoroquinolone use and resistance of Gram-positive bacteria causing healthcare-associated infections

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 6, 2012, Pages 1560-1562

  Liu, Wei Lun ^a   Chang, Ping Chin ^a   Chen, Yun Ying ^a   Lai, Chih Cheng ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Antimicrobial resistance; Antimicrobial use; Gram positive bacteria; HCAIs; Quinolones

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; GRAM POSITIVE BACTERIUM; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; PREVALENCE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; GRAM-NEGATIVE BACTERIA; HUMANS; QUINOLONES;

EID: 84861159748     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks059     Document Type: Letter

References (8)

1. Troughton JA, Millar G, Smyth ETM et al. Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics. J Antimicrob Chemother 2011; 66: 2152-8.
2. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
3. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests-Ninth Edition: Approved Standard M02-A9. CLSI, Wayne, PA, USA, 2006.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
5. Lai CC, Wang CY, Chu CC et al. Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infection at a university hospital in Taiwan from 2000 to 2009. Eur J Clin Microbiol Infect Dis 2011; 30: 265-71.
6. Kaye KS, Kanafani ZA, Dodds AE et al. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006; 50: 2192-6.
7. Lee YJ, Liu HY, Lin YC et al. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use. Int J Antimicrob Agents 2010; 35: 261-4.
8. Hsu LY, Tan TY, Tam VH et al. Surveillance of correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 2010; 54: 1173-8.